| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $14.3M | +2.7% | +5.7% |
| Cost of Revenue | $8.3M | +19.8% | +13.8% |
| R&D Expense | $1.4M | -4.1% | +13.7% |
| SG&A Expense | $12.0M | +3.1% | +97.8% |
| Operating Income | -$7.6M | -20.5% | -508.8% |
| Income Tax | $0 | — | — |
| Net Income | -$3.7M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $7.6M | +6.8% | -26.9% |
| Short-term Investments | $9.2M | -29.8% | +20.9% |
| Accounts Receivable | $5.9M | +18.3% | +34.9% |
| Inventory | $20.6M | +7.0% | +38.3% |
| Current Assets | $44.4M | -3.1% | +12.8% |
| Total Assets |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$15.4M | — | — |
| Capital Expenditures | $83K | — | — |
| Investing Cash Flow | -$3.0M | — | — |
| Financing Cash Flow | $9.8M | — | — |
| Free Cash Flow | -$15.5M | — | — |
| -147.2% |
| EPS (Basic) | -$0.31 | -106.7% | -138.5% |
| EPS (Diluted) | -$0.31 | -106.7% | -138.5% |
| $70.2M |
| -0.3% |
| +13.2% |
| Current Liabilities | $35.7M | +18.7% | +205.9% |
| Total Liabilities | $82.3M | +3.3% | +222.9% |
| Stockholders' Equity | -$25.9M | -12.4% | -213.9% |